These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 16444910

  • 1. A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.
    Castaño G, Más R, Fernández L, Illnait J, Mendoza S, Gámez R, Fernández J, Mesa M.
    Drugs Exp Clin Res; 2005; 31 Suppl():31-44. PubMed ID: 16444910
    [Abstract] [Full Text] [Related]

  • 2. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
    Castaño G, Mas R, Fernández L, Illnait J, Gámez R, Alvarez E.
    Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia.
    Castaño G, Fernández L, Mas R, Illnait J, Fernández J, Mesa M, Alvarez E, Lezcay M.
    Int J Clin Pharmacol Res; 2002; 22(2):55-66. PubMed ID: 12503776
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of policosanol Versus acipimox in patients with type II hypercholesterolemia.
    Alcocer L, Fernández L, Campos E, Más R.
    Int J Tissue React; 1999; 21(3):85-92. PubMed ID: 10645516
    [Abstract] [Full Text] [Related]

  • 5. Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment.
    Pons P, Rodríguez M, Robaina C, Illnait J, Más R, Fernández L, Fernández JC.
    Int J Clin Pharmacol Res; 1994; 14(1):27-33. PubMed ID: 7927958
    [Abstract] [Full Text] [Related]

  • 6. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G, Más R, Arruzazabala ML, Noa M, Illnait J, Fernández JC, Molina V, Menéndez A.
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [Abstract] [Full Text] [Related]

  • 7. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
    Castaño G, Fernández L, Mas R, Illnait J, Gámez R, Mendoza S, Mesa M, Fernández J.
    Drugs R D; 2005; 6(4):207-19. PubMed ID: 16050054
    [Abstract] [Full Text] [Related]

  • 8. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
    Crespo N, Illnait J, Más R, Fernández L, Fernández J, Castaño G.
    Int J Clin Pharmacol Res; 1999; 19(4):117-27. PubMed ID: 10939029
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.
    Mirkin A, Mas R, Martinto M, Boccanera R, Robertis A, Poudes R, Fuster A, Lastreto E, Yañez M, Irico G, McCook B, Farré A.
    Int J Clin Pharmacol Res; 2001; 21(1):31-41. PubMed ID: 11708573
    [Abstract] [Full Text] [Related]

  • 10. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.
    Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
    [Abstract] [Full Text] [Related]

  • 11. Concomitant use of policosanol and beta-blockers in older patients.
    Castaño G, Mas R, Gámez R, Fernández J, Illnait J, Fernández L, Mendoza S, Mesa M, Gutiérrez JA, López E.
    Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
    [Abstract] [Full Text] [Related]

  • 12. A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia.
    Canetti M, Moreira M, Mas R, Illnait J, Fernandez L, Fernandez J, Diaz E, Castano G.
    Int J Clin Pharmacol Res; 1995; 15(4):159-65. PubMed ID: 8871266
    [Abstract] [Full Text] [Related]

  • 13. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S, Gamez R, Mas R, Goicochea E.
    Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.
    Castaño G, Mas R, Fernández L, Illnait J, Mesa M, Alvarez E, Lezcay M.
    Drugs Aging; 2003; 20(2):153-63. PubMed ID: 12534315
    [Abstract] [Full Text] [Related]

  • 15. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.
    Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB.
    Am Heart J; 2006 Nov; 152(5):982.e1-5. PubMed ID: 17070175
    [Abstract] [Full Text] [Related]

  • 16. [Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia].
    Prat H, Román O, Pino E.
    Rev Med Chil; 1999 Mar; 127(3):286-94. PubMed ID: 10436712
    [Abstract] [Full Text] [Related]

  • 17. [A randomized, double-blind, placebo-controlled study of the antilipemic efficacy and tolerability of food supplement policosanol in patients with moderate hypercholesterolemia].
    Tedeschi-Reiner E, Reiner Z, Romić Z, Ivanković D.
    Lijec Vjesn; 2005 Mar; 127(11-12):273-9. PubMed ID: 16583932
    [Abstract] [Full Text] [Related]

  • 18. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors.
    Más R, Castaño G, Illnait J, Fernández L, Fernández J, Alemán C, Pontigas V, Lescay M.
    Clin Pharmacol Ther; 1999 Apr; 65(4):439-47. PubMed ID: 10223782
    [Abstract] [Full Text] [Related]

  • 19. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
    Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I.
    JAMA; 2006 May 17; 295(19):2262-9. PubMed ID: 16705107
    [Abstract] [Full Text] [Related]

  • 20. Effects of policosanol on postmenopausal women with type II hypercholesterolemia.
    Castaño G, Más R, Fernández L, Fernández JC, Illnait J, López LE, Alvarez E.
    Gynecol Endocrinol; 2000 Jun 17; 14(3):187-95. PubMed ID: 10923280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.